• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清前列腺特异性抗原水平升高患者的斯基恩氏腺腺癌:一例报告

Skene duct adenocarcinoma in a patient with an elevated serum prostate-specific antigen level: a case report.

作者信息

Tsutsumi Sohgo, Kawahara Takashi, Hattori Yusuke, Mochizuki Taku, Teranishi Jun-Ichi, Makiyama Kazuhide, Miyoshi Yasuhide, Otani Masako, Uemura Hiroji

机构信息

Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.

Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

出版信息

J Med Case Rep. 2018 Feb 14;12(1):32. doi: 10.1186/s13256-017-1558-y.

DOI:10.1186/s13256-017-1558-y
PMID:29439715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5812209/
Abstract

BACKGROUND

Female urethral carcinoma is a very rare disease that accounts for 0.02% of malignant diseases in female patients.

CASE PRESENTATION

A 70-year-old Asian Japanese woman with a urethral tumor was referred to our hospital to undergo further examination. Biopsy specimens showed urethral adenocarcinoma that was positive for prostate-specific antigen. Her serum prostate-specific antigen level before surgery was 34.4 ng/ml. Urethral tumor resection with pelvic lymph node resection was performed. Her serum prostate-specific antigen level decreased to < 0.01 ng/ml after surgery.

CONCLUSIONS

We report a very rare case of Skene duct adenocarcinoma in a female patient with serum prostate-specific antigen elevation.

摘要

背景

女性尿道癌是一种非常罕见的疾病,占女性恶性疾病的0.02%。

病例报告

一名70岁患有尿道肿瘤的亚洲日本女性被转诊至我院进行进一步检查。活检标本显示为尿道腺癌,前列腺特异性抗原呈阳性。她术前的血清前列腺特异性抗原水平为34.4 ng/ml。实施了尿道肿瘤切除术及盆腔淋巴结切除术。术后她的血清前列腺特异性抗原水平降至<0.01 ng/ml。

结论

我们报告了一例血清前列腺特异性抗原升高的女性患者发生斯基恩腺腺癌的极其罕见病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/540e/5812209/0d8c426b97e0/13256_2017_1558_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/540e/5812209/84b28acfaab0/13256_2017_1558_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/540e/5812209/4f9cd7fdae43/13256_2017_1558_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/540e/5812209/0d8c426b97e0/13256_2017_1558_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/540e/5812209/84b28acfaab0/13256_2017_1558_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/540e/5812209/4f9cd7fdae43/13256_2017_1558_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/540e/5812209/0d8c426b97e0/13256_2017_1558_Fig3_HTML.jpg

相似文献

1
Skene duct adenocarcinoma in a patient with an elevated serum prostate-specific antigen level: a case report.血清前列腺特异性抗原水平升高患者的斯基恩氏腺腺癌:一例报告
J Med Case Rep. 2018 Feb 14;12(1):32. doi: 10.1186/s13256-017-1558-y.
2
Skene's gland adenocarcinoma with increased serum level of prostate-specific antigen.斯金腺腺癌伴血清前列腺特异性抗原水平升高
Gynecol Oncol. 1994 Nov;55(2):304-7. doi: 10.1006/gyno.1994.1294.
3
[Peroperative biopsy of the sub-apical urethra during prostatectomy for cancer].[前列腺癌根治术中尿道尖部下的术中活检]
Prog Urol. 1996 Apr;6(2):250-5; discussion 255-6.
4
Prostate-specific antigen response after definitive radiotherapy for Skene's gland adenocarcinoma resembling prostate adenocarcinoma.精囊腺癌类似前列腺腺癌行根治性放疗后的前列腺特异性抗原反应。
Urol Oncol. 2012 Sep;30(5):602-6. doi: 10.1016/j.urolonc.2010.06.015. Epub 2010 Sep 25.
5
[A case of alpha-fetoprotein-producing female urethral adenocarcinoma].[一例产生甲胎蛋白的女性尿道腺癌]
Hinyokika Kiyo. 2013 Jun;59(6):373-6.
6
Skene's Gland Adenocarcinoma: Borrowing From Prostate Cancer Experience for the Evaluation and Management of a Rare Malignancy.斯基恩氏腺腺癌:借鉴前列腺癌经验对一种罕见恶性肿瘤进行评估与管理
Urology. 2021 May;151:182-187. doi: 10.1016/j.urology.2020.05.032. Epub 2020 Jun 3.
7
[Two Cases of Clear Cell Adenocarcinoma Arising in Urethral Diverticulum].[尿道憩室中发生的两例透明细胞腺癌]
Hinyokika Kiyo. 2018 Jul;64(7):307-311. doi: 10.14989/ActaUrolJap_64_7_307.
8
[Female prostate cancer?].[女性前列腺癌?]
Pathologe. 2017 Sep;38(5):448-450. doi: 10.1007/s00292-017-0322-9.
9
Skene's gland adenocarcinoma resembling prostatic adenocarcinoma.类似于前列腺腺癌的斯基恩氏腺腺癌。
Int J Gynecol Pathol. 2004 Jan;23(1):71-4. doi: 10.1097/01.pgp.0000101144.79462.39.
10
Organ Preservation for Recurrent Urethral Adenocarcinoma With Concurrent Chemotherapy and Radiation.复发性尿道腺癌同步化疗和放疗时的器官保存
Urology. 2018 Mar;113:e1-e2. doi: 10.1016/j.urology.2017.11.033. Epub 2017 Dec 2.

引用本文的文献

1
CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses.女性尿道腺癌中表达CDX2和PAX8的亚型:通过免疫组织化学和形态学分析洞察发病机制
Diagnostics (Basel). 2023 Jul 19;13(14):2408. doi: 10.3390/diagnostics13142408.
2
Skene's glands abscess an overlooked diagnosis in acute lower urinary symptoms.斯基恩氏腺脓肿——急性下尿路症状中被忽视的诊断
Radiol Case Rep. 2021 Oct 2;16(12):3751-3756. doi: 10.1016/j.radcr.2021.09.006. eCollection 2021 Dec.
3
Expression of PD-L1 and CTLA-4 in female urethral carcinoma.

本文引用的文献

1
Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic.去势抵抗性前列腺癌中雄激素受体靶向治疗:从实验室到临床
Int J Urol. 2016 Aug;23(8):654-65. doi: 10.1111/iju.13137. Epub 2016 Jun 14.
2
Proteome research in urothelial carcinoma.尿路上皮癌的蛋白质组学研究。
Int J Urol. 2015 Jul;22(7):621-8. doi: 10.1111/iju.12793. Epub 2015 May 5.
3
[Primary carcinoma of the female urethra: report of 4 cases].
Nihon Hinyokika Gakkai Zasshi. 2012 Sep;103(5):675-80. doi: 10.5980/jpnjurol.103.675.
程序性死亡受体配体1(PD-L1)和细胞毒性T淋巴细胞相关抗原4(CTLA-4)在女性尿道癌中的表达。
IJU Case Rep. 2018 Nov 23;2(1):23-26. doi: 10.1002/iju5.12029. eCollection 2019 Jan.
4
Urethral carcinoma: A compilation of case studies and research findings.尿道癌:病例研究与研究结果汇编
Urol Case Rep. 2020 Apr 3;31:101169. doi: 10.1016/j.eucr.2020.101169. eCollection 2020 Jul.
5
Three female patients with a periurethral mass: from various complaints to rare pathology.三位女性患者均有尿道周围肿块:从各种症状到罕见的病理表现。
BMJ Case Rep. 2020 Apr 9;13(4):e234086. doi: 10.1136/bcr-2019-234086.
4
Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival.女性原发性尿道癌:人口统计学因素、组织学类型、肿瘤分期和生存的流行病学研究。
World J Urol. 2013 Feb;31(1):147-53. doi: 10.1007/s00345-012-0882-5. Epub 2012 May 22.
5
Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists.回顾性分析生存结果和顺铂为基础的化疗在转至肿瘤内科医生的尿道癌患者中的作用。
Urol Oncol. 2013 Oct;31(7):1171-7. doi: 10.1016/j.urolonc.2012.01.011. Epub 2012 Apr 24.
6
Surgery for urethral cancer.尿道癌的外科治疗。
Urol Clin North Am. 2010 Aug;37(3):445-57. doi: 10.1016/j.ucl.2010.04.011.
7
MR imaging of the male and female urethra.男性和女性尿道的磁共振成像。
Radiographics. 2001 Sep-Oct;21(5):1169-85. doi: 10.1148/radiographics.21.5.g01se121169.
8
The female prostate and prostate-specific antigen. Immunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female.
Histol Histopathol. 2000 Jan;15(1):131-42. doi: 10.14670/HH-15.131.
9
Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy.女性尿道癌:治疗结果分析及对标准化管理策略的呼吁
Br J Urol. 1998 Dec;82(6):835-41. doi: 10.1046/j.1464-410x.1998.00878.x.
10
Management of primary urethral cancer.原发性尿道癌的管理
Urology. 1998 Sep;52(3):487-93. doi: 10.1016/s0090-4295(98)00199-x.